Some of the more recent additions to the standard lipid panels in clinical laboratories is the report of non‐HDL‐c (Langlois et al., 2018) and remnant cholesterol (Stürzebecher et al., 2023), but apoB is increasingly recognized as the strongest risk markers for cardiovascular disease (Sniderman et al., 2024). The gene discussed is APOB; the disease is cardiovascular disorder.